GlassScriptPhysician profile
Jeffrey Addison Michael
NPI 1760855852
$2,051.97
in general payments reported to CMS, 2019-2025
13 companies · $636 in 2025
The $636 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $330 · 2021: $256 · 2022: $101 · 2023: $293 · 2024: $289 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,218.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,314.63 | 2019-2025 | Puraply Wound Matrix, Affinity, Apligraf |
| Ets Wound Care LLC | $176.07 | 2023 | |
| Metric Medical Devices, INC. | $126.00 | 2021 | |
| Medline Industries LP | $122.89 | 2019-2020 | |
| Abbvie INC. | $115.32 | 2022-2025 | |
| Treace Medical Concepts, INC. | $53.33 | 2025 | |
| Stryker Corporation | $28.92 | 2024 | Ortholoc 3di Crosscheck |
| Paragon 28, INC. | $28.57 | 2019-2021 | |
| Smith+Nephew, INC. | $20.95 | 2025 | Oasis, Grafix |
| Bioventus LLC | $20.82 | 2025 | Exogen Ultrasound Bone Healing System |
| Hartmann USA, INC. | $16.10 | 2023 | Zetuvit Plus |
| Paratek Pharmaceuticals, INC. | $14.84 | 2024 | Nuzyra |
| Melinta Therapeutics, LLC | $13.53 | 2023 | Orbactiv, Kimyrsa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.